Eshelman School of Pharmacy, University of North Carolina at Chapel Hill.
Prime Therapeutics, Eagan, MN.
J Manag Care Spec Pharm. 2023 Apr;29(4):357-364. doi: 10.18553/jmcp.2023.29.4.357.
Value-based care is an opportunity for medication optimization services to improve medication management and reduce health care spending. The reach of these services may be extended through telehealth. However, as health care systems and payers grapple with the long-term financing of telehealth, real-world assessments are needed to evaluate the potential economic impact of pharmacy-driven telehealth services. To evaluate the impact of a scalable pharmacist-driven telehealth intervention to improve medication management on health care spending for clinically complex patients who were enrolled in a Medicare Next Generation Accountable Care Organization. Data for this pretest-posttest nonequivalent group design study came from Medicare claims from 2015 to 2020 and linked pharmacist care activity data derived from the electronic medical record. Patients in the intervention group were identified as those who received the telehealth medication management service. Patients in the control group were offered the service and refused or could not be contacted. The primary outcome was total medical spending over a 6-month period, and impact was assessed using a covariate-adjusted difference-in-difference model. There were 581 patients who received the intervention and 1,765 who served as controls. The telehealth intervention reduced total medical spending by $2,331.85 per patient over the first 6 months of the service ($388.50 per month; = 0.0261). Across a range of estimates for the cost of service delivery, we find a return on investment of 3.6:1 to 5.2:1. The $388.50 monthly savings found in this study represent a substantial reduction in health care spending and emphasize the opportunity for telehealth delivery of medication management services to improve value as a part of alternative payment models. This study was funded by the UNC Health Care Department of Pharmacy. Dr Urick has received personal fees from Pharmacy Quality Solutions and Cardinal Health. Drs Peters, Vest, Colmenares, Foushee, and DeFalco are employees of UNC Health Care Department of Pharmacy. Mr Easter received a Co-PI grant from NACDS Foundation to implement Community-based Value Care Initiative (CVCI) in a community pharmacy setting. He also received a grant to Eshelman School of Pharmacy. He has an individual consulting agreement with digital health company Truentity Health to provide go to market strategy for medication management services. He also has stock options from Truentity Health as a component of the consulting agreement. Dr Foushee has a leadership or fiduciary role at Member-At-Large and the Ambulatory Care Academy of the North Carolina Association of Pharmacists. At the time this work was conducted, Dr Urick, Dr Pathak, and Dr Blanchard were all employees of the UNC Eshelman School of Pharmacy.
基于价值的医疗保健是优化药物治疗服务以改善药物管理和降低医疗保健支出的机会。这些服务的覆盖范围可以通过远程医疗来扩大。然而,随着医疗保健系统和支付方应对远程医疗的长期融资问题,需要进行实际评估来评估药房驱动的远程医疗服务的潜在经济影响。
本研究旨在评估可扩展的药剂师驱动的远程医疗干预措施对改善参与医疗保险下一代责任医疗组织的临床复杂患者的药物管理对医疗保健支出的影响。
该前后测试非等效组设计研究的数据来自 2015 年至 2020 年的医疗保险索赔和从电子病历中得出的与药剂师护理活动数据相关联的数据。干预组中的患者被确定为接受远程医疗药物管理服务的患者。对照组中的患者提供了该服务,但拒绝或无法联系。主要结果是 6 个月期间的总医疗支出,使用协变量调整后的差异差异模型评估影响。
有 581 名患者接受了干预,1765 名患者作为对照组。远程医疗干预使每位患者在服务的头 6 个月内的总医疗支出减少了 2331.85 美元(每月 388.50 美元; = 0.0261)。在一系列服务交付成本的估计中,我们发现投资回报率为 3.6:1 至 5.2:1。本研究中发现的每月 388.50 美元的节省代表医疗保健支出的大幅减少,并强调了通过远程医疗提供药物管理服务作为替代支付模式的一部分来提高价值的机会。
这项研究由北卡罗来纳大学卫生保健部药房资助。Urick 博士从 Pharmacy Quality Solutions 和 Cardinal Health 获得个人酬金。Peters、Vest、Colmenares、Foushee 和 DeFalco 博士是北卡罗来纳大学卫生保健部药房的员工。Easter 先生从 NACDS 基金会获得了合作研究人员赠款,以在社区药房环境中实施基于社区的价值护理倡议 (CVCI)。他还获得了 Eshelman 药学院的赠款。他与数字健康公司 Truentity Health 签订了个人咨询协议,为药物管理服务提供市场推广策略。他还拥有 Truentity Health 的股票期权,作为咨询协议的一部分。Foushee 博士在北卡罗来纳州药剂师协会的全体成员和门诊护理学院担任领导或受托责任角色。在进行这项工作时,Urick 博士、Pathak 博士和 Blanchard 博士都是 UNC Eshelman 药学院的员工。